| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.60B | 1.74B | 2.01B | 1.99B | 1.64B |
| Gross Profit | 769.52M | 842.59M | 1.01B | 1.08B | 877.72M |
| EBITDA | 20.86M | 117.54M | 187.83M | 257.77M | 222.53M |
| Net Income | 9.02M | 28.44M | 77.07M | 139.01M | 118.36M |
Balance Sheet | |||||
| Total Assets | 575.73M | 650.10M | 704.57M | 794.94M | 724.46M |
| Cash, Cash Equivalents and Short-Term Investments | 31.38M | 95.35M | 90.14M | 131.48M | 153.98M |
| Total Debt | 132.25M | 136.79M | 110.93M | 109.83M | 102.34M |
| Total Liabilities | 361.10M | 387.69M | 398.09M | 442.74M | 384.35M |
| Stockholders Equity | 214.63M | 262.41M | 306.49M | 352.20M | 340.11M |
Cash Flow | |||||
| Free Cash Flow | 40.10M | 110.99M | 121.63M | 152.99M | 120.32M |
| Operating Cash Flow | 50.06M | 126.66M | 153.01M | 184.66M | 148.69M |
| Investing Cash Flow | -11.38M | -13.73M | -28.56M | -29.59M | -25.73M |
| Financing Cash Flow | -103.51M | -106.09M | -156.76M | -183.53M | -131.19M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £35.32M | 5.49 | 11.07% | 3.35% | 2.40% | 1101.69% | |
69 Neutral | £182.38M | 12.17 | 7.83% | 6.35% | -13.93% | -48.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | £49.52M | 11.41 | 13.11% | ― | 1.44% | ― | |
48 Neutral | £426.99M | 81.54 | 4.18% | 7.58% | -12.54% | -76.55% | |
46 Neutral | £57.22M | -3.34 | -24.67% | 12.88% | -14.31% | -361.93% | |
45 Neutral | £513.64M | 748.65 | -2.24% | 1.76% | -4.92% | -58.06% |